Incidence of Posttransplant Hypertension Among Renal Allograft Recipients

Malekhosseini, Seyed Ali; Ghahramani, Nasrollah; Behzadi, S; Rais-Jalali, G.A; Ahmad, Ejaz; Salahi, H; Nezakatgoo, Nosratollah; Javid, R; Rad, Steve

doi:10.1016/s0041-1345(98)00043-8

Cited by 8 publications

(5 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The main reason why HT failed to be a predictor of stroke in our RTR may be the high prevalence of HT amongst them, which makes differences between both groups not statistically significant. Although HT has been widely reported in RTR (15–17), our study showed that patients who suffered stroke had a higher prevalence of HT than those who did not. Some studies have revealed that HT is a main predictor of extracranial cerebrovascular atherosclerosis after RT (7).…”

Section: Discussioncontrasting

confidence: 68%

Stroke in renal transplant recipients: epidemiology, predictive risk factors and outcome

Oliveras¹,

Roquer

Puig³

et al. 2003

Clinical Transplantation

View full text Add to dashboard Cite

show abstract

Section: Discussioncontrasting

confidence: 68%

Stroke in renal transplant recipients: epidemiology, predictive risk factors and outcome

Oliveras¹,

Roquer

Puig³

et al. 2003

Clinical Transplantation

View full text Add to dashboard Cite

show abstract

“…The number of antihypertensive medications required in more recent transplants also increased compared to patients who were transplanted earlier (9). Overall prevalence of post-transplant HTN has ranged from 24 to 90% (5,(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19).…”

Section: Epidemiology Of Post-transplant Hypertensionmentioning

confidence: 99%

“…Different studies have defined posttransplant HTN with different cutoff levels for systolic and diastolic blood pressure (SBP and DBP) and different requirements for the use of antihypertensive medications. Table 1 summarizes the details of these studies (8,9,(16)(17)(18).…”

Section: Definition Of Post-transplant Hypertensionmentioning

confidence: 99%

“…Post-transplant HTN requires developing de novo HTN after kidney transplant (Figure 1). Malek-Hosseini et al (17) reported the incidences of persistent HTN, recovered HTN, persistent normotension, and posttransplant HTN as 40, 28, 13, and 19%, respectively. In this review, post-kidney transplant HTN refers to persistent and post-transplant (de novo) HTN unless otherwise specified.…”

Section: Definition Of Post-transplant Hypertensionmentioning

confidence: 99%

See 1 more Smart Citation

Approach and Management of Hypertension After Kidney Transplantation

Tantisattamo

Molnár

et al. 2020

Front. Med.

View full text Add to dashboard Cite

“…[36][37][38] In 1 study, 500 donors were invited to participate and only 6 responded. 14 In the largest available study of donors, the maximum follow-up was 4 years.…”

Section: Discussionmentioning

confidence: 99%

Paid Living Donation and Growth of Deceased Donor Programs

Ghahramani¹

2016

Transplantation

View full text Add to dashboard Cite

Limited organ availability in all countries has stimulated discussion about incentives to increase donation. Since 1988, Iran has operated the only government-sponsored paid living donor (LD) kidney transplant program. This article reviews aspects of the Living Unrelated Donor program and development of deceased donation in Iran. Available evidence indicates that in the partially regulated Iranian Model, the direct negotiation between donors and recipients fosters direct monetary relationship with no safeguards against mutual exploitation. Brokers, the black market and transplant tourism exist, and the waiting list has not been eliminated. Through comparison between the large deceased donor program in Shiraz and other centers in Iran, this article explores the association between paid donation and the development of a deceased donor program. Shiraz progressively eliminated paid donor transplants such that by 2011, 85% of kidney transplants in Shiraz compared with 27% across the rest of Iran's other centers were from deceased donors. Among 26 centers, Shiraz undertakes the largest number of deceased donor kidney transplants, most liver transplants, and all pancreas transplants. In conclusion, although many patients with end stage renal disease have received transplants through the paid living donation, the Iranian Model now has serious flaws and is potentially inhibiting substantial growth in deceased donor organ transplants in Iran.

show abstract

Incidence of Posttransplant Hypertension Among Renal Allograft Recipients

Cited by 8 publications

References 5 publications

Stroke in renal transplant recipients: epidemiology, predictive risk factors and outcome

Stroke in renal transplant recipients: epidemiology, predictive risk factors and outcome

Approach and Management of Hypertension After Kidney Transplantation

Paid Living Donation and Growth of Deceased Donor Programs

Contact Info

Product

Resources

About